Josh Nichols

Luke Junk

Joseph Spak

Ryan Brinkman

David Whiston

Mark Delaney

Jake Scholl

James Picariello

Ronald Jewsikow

Charles Sloan

Joe Spak

Ron Jewsikow

- **Gentex Corporation** has been selected by the Czech Ministry of Defence to deliver next-generation **Ops-Core integrated ballistic helmet systems** and **AMP® Communication Headsets** to soldiers across the Czech Armed Forces.  **[355811_71a647a6c23e46f9a5be8aa2b520af6c_0]** 
- The contract, valued at over **1 billion CZK**, was placed through the NATO Support and Procurement Agency (NSPA) under the NATO Logistics Stock Exchange (NLSE) contract.  **[355811_71a647a6c23e46f9a5be8aa2b520af6c_0]** 
- The delivery of these advanced headborne systems and accessories is scheduled for completion by **October 2026**.  **[355811_71a647a6c23e46f9a5be8aa2b520af6c_0]** **[355811_71a647a6c23e46f9a5be8aa2b520af6c_1]** 
- The products are designated for various units, including brigade task forces within the 4th Rapid Deployment Brigade and the 7th Mechanized Brigade, as well as personnel across ground forces, support elements, special operations forces, the Military Police, and the Cyber and Information Operations Command.  **[355811_71a647a6c23e46f9a5be8aa2b520af6c_1]**

Gentex Corporation Selected by Czech Ministry of Defence

- Gentex reported **Q3 2025 consolidated net sales of $655.2 million**, an **8% increase** compared to the prior year, with **VOXX contributing $84.9 million**.  **[0000355811_2202307_1]**  Core Gentex revenue for the quarter was **$570.3 million**, representing a 6% decline.  **[0000355811_2202307_1]** 
- Consolidated net income attributable to Gentex for Q3 2025 was **$101 million**, leading to **$0.46 earnings per diluted share**.  **[0000355811_2202307_2]**  This compares to $122.5 million and $0.53, respectively, in the prior year, with the change primarily due to a one-time gain in the prior period related to the fair value adjustment of the company's original investment in VOXX.  **[0000355811_2202307_2]** 
- The company's **consolidated gross margin improved to 34.4%** in Q3 2025, up from 33.5% in the third quarter of last year, driven by favorable North American customer and product mix, purchasing cost reductions, and operational efficiencies.  **[0000355811_2202307_1]** 
- Gentex updated its **full-year 2025 guidance**, projecting consolidated revenue between **$2.5 billion and $2.6 billion** and a consolidated gross margin of **33.5% to 34%**.  **[0000355811_2202307_5]** 
- During Q3 2025, the company repurchased **1 million shares** of its common stock for a total of **$28.3 million**.  **[0000355811_2202307_3]**  Gentex also confirmed it is on track to achieve **$40 million** in annual free cash flow from VOXX synergies within 18 months post-acquisition, having already realized over **$10 million** in annualized savings.  **[0000355811_2202307_9]**

Gentex Reports Q3 2025 Results with Increased Sales and Updated Full-Year Guidance

- **Consolidated net sales for Q3 2025 reached $655.2 million**, an **8% increase** year-over-year, primarily driven by the **VOXX acquisition which contributed $84.9 million**.  **[0000355811_2202285_1]**  Core Gentex revenue saw a **6% decline**.  **[0000355811_2202285_1]** 
- **Consolidated gross margin improved to 34.4%** in Q3 2025, up from 33.5% in the prior year.  **[0000355811_2202285_1]**  However, **consolidated net income decreased to $101 million** and **diluted EPS to $0.46**, largely due to a one-time gain in the prior year related to the VOXX investment.  **[0000355811_2202285_2]** 
- The company updated its **full-year 2025 guidance**, projecting consolidated revenue between **$2.5 billion and $2.6 billion** and consolidated gross margin between **33.5% and 34%**.  **[0000355811_2202285_6]** 
- Gentex repurchased **1 million shares** for **$28.3 million** in Q3 2025, contributing to **$230.5 million** in year-to-date share repurchases.  **[0000355811_2202285_3]** 
- Integration of the VOXX acquisition is progressing, with over **$10 million in annualized savings** achieved and a target of **$40 million in annual free cash flow** from VOXX within **18 months post-acquisition**.  **[0000355811_2202285_10]**

Gentex Reports Q3 2025 Results and Updates Full-Year Guidance

- Gentex reported **consolidated net sales of $655.2 million** for Q3 2025, an **8% increase** compared to the prior year, with **VOXX contributing $84.9 million** to revenue. Core Gentex revenue, excluding VOXX, declined **6%** to **$570.3 million**.  **[0000355811_2202629_1]** 
- The company's consolidated gross margin improved to **34.4%** in Q3 2025, up from 33.5% in the prior year, despite a **90 basis point negative impact from incremental tariffs**.  **[0000355811_2202629_1]**  Core Gentex gross margin was **34.9%**.  **[0000355811_2202629_1]** 
- Consolidated net income attributable to Gentex for Q3 2025 was **$101 million**, and diluted earnings per share (EPS) was **$0.46**. This compares to $122.5 million net income and $0.53 EPS in Q3 2024, which included a one-time gain related to the fair value adjustment of the VOXX investment.  **[0000355811_2202629_2]** 
- Gentex updated its full-year 2025 guidance, projecting consolidated revenue (including VOXX) between **$2.5 billion and $2.6 billion** and consolidated gross margin between **33.5% and 34%**.  **[0000355811_2202629_6]** 
- During Q3 2025, the company repurchased **1 million shares** of its common stock for a total of **$28.3 million** at an average price of **$28.18 per share**.  **[0000355811_2202629_3]**  The VOXX acquisition is noted as **positive on net income** and **accretive on EPS**.  **[0000355811_2202629_9]**

Gentex Reports Q3 2025 Financial Results with Revenue Growth Driven by VOXX Acquisition

- Gentex reported **consolidated net sales of $655.2 million** for the third quarter of 2025, an **8% increase** compared to the prior year, with **VOXX contributing $84.9 million** in revenue.  **[0000355811_2202728_1]**  Core Gentex revenue saw a 6% decline.  **[0000355811_2202728_1]** 
- The company achieved a **consolidated gross margin of 34.4%** in Q3 2025, an increase from 33.5% in the third quarter of last year, with **core Gentex gross margin improving by 140 basis points to 34.9%**.  **[0000355811_2202728_1]** 
- **Consolidated net income attributable to Gentex was $101 million**, leading to **earnings per diluted share of $0.46** for Q3 2025, compared to $122.5 million and $0.53 respectively in Q3 2024, primarily due to a one-time gain in the prior period related to the fair value adjustment of the VOXX investment.  **[0000355811_2202728_2]** 
- Gentex **repurchased 1 million shares** of its common stock for **$28.3 million** during the third quarter of 2025.  **[0000355811_2202728_3]** 
- The company updated its **full-year 2025 guidance**, projecting **consolidated revenue between $2.5 billion and $2.6 billion** and a **consolidated gross margin of 33.5% to 34%**.  **[0000355811_2202728_5]**

Gentex Reports Q3 2025 Financial Results with Increased Consolidated Sales and Updated Full-Year Guidance

- Gentex reported **consolidated net sales of $655.2 million** for Q3 2025, an **8% increase** compared to Q3 2024, with **core Gentex net sales (excluding VOXX) at $570.3 million**.  **[0000355811_2202012:4]** 
- In Q3 2025, the company achieved a **consolidated gross margin of 34.4%** and **consolidated earnings per diluted share of $0.46**.  **[0000355811_2202012:4]** 
- Gentex repurchased **1.0 million shares totaling $28.3 million** during Q3 2025, contributing to **$230.5 million** in share repurchases year-to-date 2025 as of October 24, 2025.  **[0000355811_2202012:4]** **[0000355811_2202012:5]** 
- The company updated its 2025 consolidated guidance, forecasting **revenue between $2.5 billion and $2.6 billion** and a **gross margin of 33.5% to 34%**.  **[0000355811_2202012:4]**

Gentex Reports Q3 2025 Results and Updates 2025 Guidance

- **Gentex Corporation reported Q3 2025 consolidated net sales of $655.2 million**, an **8% increase** year-over-year, with **VOXX contributing $84.9 million**.  **[355811_0000355811-25-000047_exhibit99109302025.htm:0]** **[355811_0000355811-25-000047_exhibit99109302025.htm:1]**  However, **core Gentex net sales (excluding VOXX) declined by 6%** to **$570.3 million** compared to Q3 2024.  **[355811_0000355811-25-000047_exhibit99109302025.htm:0]** **[355811_0000355811-25-000047_exhibit99109302025.htm:1]** 
- The company achieved a **consolidated gross margin of 34.4%** in Q3 2025, an increase of **90 basis points** from Q3 2024, and a **core Gentex gross margin of 34.9%**, up **140 basis points**.  **[355811_0000355811-25-000047_exhibit99109302025.htm:0]** **[355811_0000355811-25-000047_exhibit99109302025.htm:1]** 
- **Consolidated earnings per diluted share attributable to Gentex were $0.46** for Q3 2025, down from $0.53 in Q3 2024, primarily due to a one-time gain in the prior year related to the VOXX investment.  **[355811_0000355811-25-000047_exhibit99109302025.htm:0]** **[355811_0000355811-25-000047_exhibit99109302025.htm:2]** 
- Gentex **updated its full-year 2025 guidance**, with **consolidated revenue now projected between $2.50 \u2013 $2.60 billion** and **gross margin between 33.5% \u2013 34%**.  **[355811_0000355811-25-000047_exhibit99109302025.htm:4]** 
- During the third quarter of 2025, the company **repurchased 1.0 million shares** of its common stock for **$28.3 million**.  **[355811_0000355811-25-000047_exhibit99109302025.htm:0]** **[355811_0000355811-25-000047_exhibit99109302025.htm:3]**

Gentex Reports Third Quarter 2025 Financial Results

- Gentex Corporation reported **consolidated net sales of $655.2 million** for the third quarter of 2025, an **8% increase** compared to the third quarter of 2024, which did not include VOXX.  **[355811_c17a65d86e034c9a96fb458214298bcd_0]** **[355811_c17a65d86e034c9a96fb458214298bcd_1]**  VOXX contributed **$84.9 million** in revenue during Q3 2025.  **[355811_c17a65d86e034c9a96fb458214298bcd_1]** **[355811_c17a65d86e034c9a96fb458214298bcd_3]** 
- For the third quarter of 2025, the company achieved **consolidated net income attributable to Gentex of $101.0 million** and **diluted earnings per share of $0.46**.  **[355811_c17a65d86e034c9a96fb458214298bcd_0]** **[355811_c17a65d86e034c9a96fb458214298bcd_10]** 
- The **consolidated gross margin was 34.4%** in Q3 2025, an increase of 90 basis points from Q3 2024, while the **core Gentex gross margin (excluding VOXX) was 34.9%**, up 140 basis points compared to 33.5% in the prior year period.  **[355811_c17a65d86e034c9a96fb458214298bcd_0]** **[355811_c17a65d86e034c9a96fb458214298bcd_1]** 
- During the third quarter of 2025, Gentex repurchased **1.0 million shares** of its common stock for a total of **$28.3 million**.  **[355811_c17a65d86e034c9a96fb458214298bcd_0]** **[355811_c17a65d86e034c9a96fb458214298bcd_3]** 
- The company updated its **full-year 2025 guidance** as of October 24, 2025, with consolidated revenue now projected between **$2.50 – $2.60 billion** and gross margin between **33.5% – 34%**.  **[355811_c17a65d86e034c9a96fb458214298bcd_5]**

GENTEX (GNTX)